| || |
| || |
| Ned David, PhD |
Founder, Syrrx, Inc.
Founder of Syrrx, Inc., a proteomics company in San Diego that specializes in x-ray crystallography and determining protein structure for use in drug discovery.
Stanley Fields, PhD
Professor of Genetics and Medicine
Fields is a professor of genome sciences and medicine, and adjunct professor of microbiology at the University of Washington. He analyzes the function of proteins from the yeast Saccharomyces cerevisiae on a genome-wide basis, and uses this yeast to develop assays that can be applied to proteins from any organism. In 1989 Fields and his colleagues developed a methodology for finding protein interactions, called the two-hybrid system. Since that time, other methods have been developed and used with success, but Fields' system has become the dominant tool among researchers throughout the world.
Molecular and Cellular Biologist
Fraser is a UC Berkeley doctoral candidate. His research on the evolution of protein interactions, in collaboration with Aaron Hirsch, was published in the journals Science and Nature.
Hirsh is a graduate student in Marcus Fieldman's lab at Stanford University. His paper on the evolution of protein interactions, in collaboration with Hunter Fraser, was published in the journals of Science and Nature.
Leroy Hood, PhD
President, Institute for Systems Biology
Hood played a key factor in the Human Genome Project and was credited with developing the automated sequencer. He is recognized as one of the world's leading scientists in molecular biotechnology and genomics. Hood created the cross-disciplinary Department of Molecular Biotechnology at the University of Washington, bringing together chemists, engineers, computer scientists, applied physicists, and biologists. He has recently created the Institute for Systems Biology in Seattle, Washington, and serves as its president. Recently, Hood's lifelong contributions to biotechnology have earned him the prestigious Lemelson-MIT Prize for Invention and Innovation.